Acetylsalicylic acid Completed Phase 3 Trials for Dyslipidemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00630877Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin
NCT00626392Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on NiaspanĀ®-Induced Flushing in Subjects With Dyslipidemia